Astellas Pharma | 4503 - Cost Of Sales


Astellas Pharma reported JPY158.38B in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Astellas Pharma JPY 158.38B 28.94B Jun/2026
Chugai Pharma JPY 104.22B 11.43B Jun/2026
Daiichi Sankyo JPY 124.29B 6.02B Jun/2026
Eisai JPY 51.09B 926M Jun/2026
Kyowa Hakko Kirin JPY 39.13B 6.13B Jun/2026
M3 JPY 45.64B 558M Jun/2026
Otsuka Holdings JPY 191.82B 17.73B Jun/2026
Shionogi JPY 46.62B 13.95B Jun/2026
Sumitomo Dainippon JPY 61.41B 10.15B Jun/2026
Takeda JPY 517.6B 42.94B Jun/2026
Terumo JPY 133.27B 18.03B Jun/2026